Australian Clinical Labs Ltd
ASX:ACL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Australian Clinical Labs Ltd
ASX:ACL
|
AU |
|
C
|
CU Medical Systems Inc
KOSDAQ:115480
|
KR |
|
S
|
Samchai Steel Industries PCL
SET:SAM
|
TH |
|
Mondo TV SpA
MIL:MTV
|
IT |
|
GI Engineering Solutions Ltd
NSE:GISOLUTION
|
IN |
|
Ubicom Holdings Inc
TSE:3937
|
JP |
|
A
|
Artifex Mundi SA
WSE:ART
|
PL |
|
Bufab AB (publ)
STO:BUFAB
|
SE |
|
T
|
Tamburi Investment Partners SpA
F:T1I
|
IT |
|
S
|
Sherwood Corporation (Thailand) PCL
SET:SWC
|
TH |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
Dividends
Dividend Yield
Australian Clinical Labs Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Australian Clinical Labs Ltd
ACL have decreased by 0%.
Payout Ratio
Australian Clinical Labs Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for ACL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ACL Price
Australian Clinical Labs Ltd
| Average Annual Return | 2.74% |
| Standard Deviation of Annual Returns | 36.47% |
| Max Drawdown | -66% |
| Market Capitalization | 512.6m AUD |
| Shares Outstanding | 186 520 000 |
| Percentage of Shares Shorted |
N/A
|
